Panel Discussion: Overcoming the Limitations of Dry AMD not having a Recognised Disease Model
Time: 11:00 am
day: Conference Day 1
Details:
- Incorporating more NHPs in preclinical testing to better inform the safety profile of dry AMD therapeutics
- Understanding why developing a relevant animal model for Dry AMD remains a pertinent challenge
